[Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
D000721:Ancrod / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000097:blood / Q000188:drug therapy*; D012103:Batroxobin / Q000627:therapeutic use*; D001809:Blood Viscosity / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D010447:Peptide Hydrolases / Q000627:therapeutic use*
D010447:Peptide Hydrolases; D000721:Ancrod; D012103:Batroxobin
Therapeutische Defibrinogenierung als konservative Therapie der peripheren arteriellen Verschlusskrankheit. Eine kritische Analyse.